Human RTN4/ASY/Nbla00271 ORF/cDNA clone-Adenovirus particle (NM_153828.3)
Cat. No.: vGMAD001226
Pre-made Human RTN4/ASY/Nbla00271 Adenovirus for RTN4 overexpression in-vitro and in-vivo. The RTN4 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified RTN4-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
RTN4/ASY products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
vGMAD001226 | Human RTN4 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
5E+10PFU (1E+10pfu/ml×5ml) | |||
1E+11PFU (1E+10pfu/ml×10ml) | |||
Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMAD001226 |
Gene Name | RTN4 |
Accession Number | NM_153828.3 |
Gene ID | 57142 |
Species | Human |
Product Type | Adenovirus particle (overexpression) |
Insert Length | 1122 bp |
Gene Alias | ASY,Nbla00271,Nbla10545,NI220/250,NOGO,NSP,NSP-CL,RTN-X,RTN4-A,RTN4-B1,RTN4-B2,RTN4-C |
Fluorescent Reporter | EGFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Kanamycin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Biosimilar | GMP-Bios-ab-037 | Pre-Made Atinumab biosimilar, Whole mAb, Anti-RTN4 Antibody: Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2 therapeutic antibody |
Biosimilar | GMP-Bios-ab-418 | Pre-Made Ozanezumab biosimilar, Whole mAb, Anti-RTN4 Antibody: Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2 therapeutic antibody |
Target Antibody | GM-Tg-g-T70062-Ab | Anti-RTN4/ ASY/ NI220/250 monoclonal antibody |
Target Antigen | GM-Tg-g-T70062-Ag | RTN4 VLP (virus-like particle) |
ORF Viral Vector | pGMLP002802 | Human RTN4 Lentivirus plasmid |
ORF Viral Vector | pGMLV001875 | Human RTN4 Lentivirus plasmid |
ORF Viral Vector | pGMAD001226 | Human RTN4 Adenovirus plasmid |
ORF Viral Vector | pGMPC000891 | Human RTN4 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLP002802 | Human RTN4 Lentivirus particle |
ORF Viral Vector | vGMLV001875 | Human RTN4 Lentivirus particle |
ORF Viral Vector | vGMAD001226 | Human RTN4 Adenovirus particle |
Target information
Target ID | GM-T70062 |
Target Name | RTN4 |
Gene ID | 57142, 68585, 619181, 83765, 101091611, 474598, 359718, 100066612 |
Gene Symbol and Synonyms | 1110020G17Rik,ASY,C130026I10Rik,mKIAA0886,mKIAA4153,Nbla00271,Nbla10545,NgA,NI-250,NI220/250,NOGO,Nogo-A,Nogo-B,Nogo-C,NSP,NSP-CL,rat N,rat NogoA,RTN-X,RTN4,RTN4-A,RTN4-B1,RTN4-B2,RTN4-C,RTN4-Cw,Vp20 |
Uniprot Accession | Q9NQC3 |
Uniprot Entry Name | RTN4_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index |
Disease | Not Available |
Gene Ensembl | ENSG00000115310 |
Target Classification | Not Available |
This gene belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. The product of this gene is a potent neurite outgrowth inhibitor which may also help block the regeneration of the central nervous system in higher vertebrates. Alternatively spliced transcript variants derived both from differential splicing and differential promoter usage and encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.